Tag: CSIR
CSIR-CDRI licenses nucleic acid staining dye tech to GenetoProtein
The dye GreenR™ has been developed by CDRI Senior Principal Scientist Dr. Atul Goel in a joint collaborative project with an industry partner Biotech Desk Private Limited, Hyderabad
New insights into COVID-19 RNA variations & their implications
The researchers have also studied the fixation of these intra-host variations into extra-host variations and mutations that lead to variants
Dr D. Srinivasa Reddy gets additional charge of Director, CSIR-CDRI
Director, CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu, Dr. D. Srinivas Reddy has a good amalgamation of research experience from the pharmaceutical Industry and research institutes
Union S&T Minister emphasizes criticality of digital medicine
Tele-medicine and robotic surgery have already taken over in a big way and the indispensable utility of these new options was realised during the pandemic times, noted Dr Jitendra Singh
CSIR-CDRI scientists develop indigenous RT-PCR kit ‘Om’ for Omicron variant
Under the Government initiative to make India self-reliant in RT-PCR diagnostics, CDRI developed an indigenous RT-PCR diagnostic kit
Study identifies genetic risk factors for heart failure
A gene called β-MYH7 is one of the major genes implicated in cardiac diseases globally
Dr Jitendra Singh proposes single application for all scientific fellowships, grants...
The streamlining of the fellowships and research grants will not only save cost and time but will provide a level playing field to all the students and help achieve “ease of science education” for students and scholars
CSIR-IICT to upskill students from North-Eastern states in a joint move
Indian Institute of Chemical Technology (IICT) will provide the students from the North-Eastern (NE) states with more advanced skills and training, jointly with Cipla, an Indian pharmaceutical company, headquartered in Mumbai.
CSIR-CDRI transfers tech to Marc Labs, aims to develop safer drug...
Central Drug Research Institute has recently obtained the permission to initiate the Phase I clinical trials for the new safer drug for heart attack and stroke expected to be in the market soon
FIND & CSIR-IGIB partner to strengthen genomic surveillance of SARS-CoV-2 in...
The partnership will serve to optimize and scale the capacity needed to identify SARS-CoV-2 variants of concern (VOC) and variants of interest (VOI)